Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Top questions on the minds of QPPV

Posted on December 21st, 2016 by in Pharmacovigilance

The 2016 Pharmacovigilance Days (PHV Day 2016) kicked off in early April 2016 in Berlin, Germany. Afterwards, the tour continued to Amsterdam, London, Copenhagen, Rome and Paris in October and November. With the objective of bringing together safety experts from the pharmaceutical and healthcare industry Continue reading “Top questions on the minds of QPPV” »

The Expanding Role of PV in Pre-marketing Activities

Posted on September 7th, 2016 by in Pharmacovigilance

There is an inherent challenge in bringing Pharmacovigilance expertise into the development phase of medicinal products for the first time, especially for small pharmaceutical companies. Continue reading “The Expanding Role of PV in Pre-marketing Activities” »

Smart Devices, Big Data, and the Value of Long-Term Research

Posted on August 29th, 2016 by in Pharma R&D

In a new feature in The Atlantic, author Jessa Gamble makes the case that Modern Medicine Is Too Reliant on Short-Term Studies, too often preferring the instant gratification that comes from a short study, only to find those results soon challenged by yet another short-term study.

Continue reading “Smart Devices, Big Data, and the Value of Long-Term Research” »

When drugs collide ….

Posted on July 15th, 2016 by in Pharmacovigilance

Pharmaceutical companies increasingly are adopting “proactive pharmacovigilance” and other strategies to help ensure the safety of a new entity as early as possible in the discovery/development process. Continue reading “When drugs collide ….” »

  1. 1
  2. 2
  3. 3